Transgenic studies on the regulation of the anterior pituitary gland function by the hypothalamus

Frontiers in Neuroendocrinology

Volumn 24, Issue 1, 2003, Pages 11-26

  Wells, Sara ^a,b   Murphy, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Medical Research Council Harwell Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN;

ADENOHYPOPHYSIS; GENE EXPRESSION; GENE TRANSFER; GROWTH REGULATION; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HYPOTHALAMUS; LACTATION; METABOLIC REGULATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REPRODUCTION; REVIEW; STRESS; TRANSGENE; TRANSGENICS;

EID: 0037288565     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3022(02)00103-6     Document Type: Review

References (135)

1. Al-Shawi R., Kinnaird J., Burke J., Bishop J.O. Expression of a foreign gene in a line of transgenic mice is modulated by chromosomal position effect. Mol. Cell. Biol. 10:1990;1192-1198.
2. Ang H.-L., Carter D.A., Murphy D. Neuron-specific and physiological regulation of bovine vasopressin transgenes in mice. EMBO J. 12:1993;2397-2409.
3. Aronow B.J., Ebert C.A., Valerius M.T., Potter S.S., Wiginton D.A., Witte D.P., Hutton J.J. Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequeces. Mol. Cell. Biol. 15:1995;1123-1135.
4. Balkan W., Tavianin M.A., Gkonos P.J., Roos B.A. Expression of rat thyrotropin-releasing hormone (TRH) gene in TRH-producing tissues of transgenic mice requires sequences located in exon I. Endocrinol. 139:1998;252-259.
5. Banerji J., Olson L., Schaffner W. A lymphocytes-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell. 33:1983;729-740.
6. ′ -Flanking sequences of the tyrosine hydroxylase gene target accurate tissue-specific, developmental, and transsynaptic expression in transgenic mice J. Neurosci. 12:1992;4460-4467.
7. Banerjee S.A., Roffler-Tarlov S., Szabo M., Frohman L., Chikaraishi D.M. DNA regulatory sequences of the rat tyrosine hydroxylase gene direct correct catecholaminergic cell-type specificity of a human growth hormone reporter in the CNS of transgenic mice causing a dwarf phenotype. Mol. Brain Res. 24:1994;89-106.
8. Barinaga M., Yamonoto G., Rivier G., Vale W., Evans R., Rosenfeld M.G. Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor. Nature. 306:1987;84-85.
9. Behringer R.R., Mathews L.S., Palmiter R.D., Brinster R.L. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev. 2:1988;453-461.
10. Ben-Jonathan N. Dopamine: a prolactin-inhibiting hormone. Endocr. Rev. 6:1985;565-589.
11. Bjorklund S., Kim Y.-J. Mediator of transcription regulation. Trends Biochem. Sci. 21:1996;335-337.
12. Bonifer C., Hecht A., Saueressig H., Winter H., Winter D.M., Sippel A.E. Dynamic chromatin: the regulatory domin organization of eukaryotic gene loci. J. Cell. Biochem. 47:1991;99-108.
13. Bonifer C., Vidal M., Grosveld F., Sippel A.E. Tissue-specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO J. 9:1990;2843-2848.
14. Borrelli E., Heyman R.A., Arias L., Sawchenko P.E., Evans R.M. Transgenic mice with inducible dwarfism. Nature. 339:1989;538-541.
15. Bosma M.M. Ion channel properties and episodic activity in isolated immortalized gonadotropin-releasing hormone (GnRH) neurons. J. Membr. Biol. 136:1993;85-96.
16. Botteri F.M., van der Putten H., Wong D.F., Sauvage C.A., Evans R.M. Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen. Mol. Cell. Biol. 7:1987;3178-3184.
17. Brazeau P., Vale W., Burgus R., Ling L., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 179:1973;77-79.
18. D.R. Brenin, J. Look, N. Hubner, G. Levan, P.H. Iannaccone, Pluripotent embryonic stem cells from the rat are capable of producing chimeras (erratum), Dev. Biol. 185 (1997) 124-125.
19. Brinster R.L., Chen H.Y., Trumbauer M. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell. 27:1981;223-231.
20. Brinster R.L., Chen H.Y., Warren R., Sarthy A., Palmiter R.D. Regulation of metallothionein-thymidine kinase fusion plasmids injected into mouse eggs. Nature. 296:1982;39-42.
21. Brook F.A., Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA. 94:1997;5709-5712.
22. Burrows H.L., Nakajima M., Lesh J.S., Goosens K.A., Samuelson L.C., Inui A., Camper S.A., Seasholtz A.F. Excess corticotropin-releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice. J. Clin. Invest. 101:1998;1439-1447.
23. Burton F.H., Hasel K.W., Bloom F.E., Sutcliffe J.G. Pituitary hyperplasia and gigantism in mice caused by cholera toxin transgene. Nature. 350:1991;74-76.
24. Butcher J.W., De Felipe C., Smith A.J., Hunt S.P., Paton J.F. Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo. J. Autonom. Nerv. Syst. 69:1998;89-95.
25. ′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in drosophila Cell. 74:1993;505-514.
26. Clark R.G., Carlsson L.M.S., Robinson I.C.A.F. Growth hormone secretory profiles in conscious female rats. J. Endocrinol. 114:1987;399-407.
27. I.J. Clarke, What can we learn from sampling hypophysial portal blood? in: Functional anatomy of the neuroendocrine hypothalamus, Ciba F. Symp. 168 (1992) 87-103.
28. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9:1995;1608-1621.
29. Costantini F., Lacy E. Introduction of a rabbit β-globin gene into the mouse germ line. Nature. 294:1981;92-94.
30. Dijkstra I., Tilders F.J.H., Aguilera G., Kiss A., Rabadan-Diehl C., Barden N., Karanth S., Holsboer F., Reul J.M.H.M. Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. J. Neurosci. 18:1998;3909-3918.
31. Evans J.J. Modulation of gonadotropin levels by peptides acting at the anterior pituitary. Endocr. Rev. 20:1999;46-67.
32. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature. 292:1981;154-156.
33. Flavell D.M., Wells T., Wells S.E., Carmignac D.F., Thomas G.B., Robinson I.C.A.F. Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons. EMBO J. 15:1996;3871-3879.
34. Forrester W.C., Epner E., Driscoll M.C., Enver T., Brice M., Papayannopoulou T., Groudine M. A deletion of the human β-globin locus activation region causes a major alteration in chromatin structure and replication across the entire β-globin locus. Genes Dev. 4:1990;1637-1649.
35. Fraser P., Hurst J., Collis P., Grosveld F. DNase I hypersensitive sites 1, 2 and 3 of the human β-globin dominant control region direct position-independent expression. Nucleic Acid Res. 18:1990;3503-3508.
36. Gillies G.E., Linton E.A., Lowry P.J. Corticotrophin-releasing activity of the new CRF is potientiated several times by vasopressin. Nature. 299:1982;355-357.
37. Gillies G.E., Lowry P. Corticotrophin releasing factor may be modulated by vasopressin. Nature. 278:1979;463-464.
38. Gillies S.D., Morrison S.L., Oi V.T., Tonegawa S. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell. 33:1983;717-728.
39. Gilman A.G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:1987;615-649.
40. Giraldi F.P., Mizobuchi M., Horowitz Z.D., Downs T.R., Aleppo G., Kier A., Wagner T., Yun J.S., Kopchick J.J., Frohman L.A. Development of the neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene. Endocrinology. 134:1994;1219-1224.
41. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. N. Engl. J. Med. 319:1988;413-420.
42. Granjeaud S., Bertucci F., Jordan B.R. Expression profiling: DNA arrays in many disguises. BioEssays. 21:1999;781-790.
43. Greenspan F.S., Forsham P.H. Basic and Clinical Endocrinology. second ed. 1986;Lange Medical Publications, Los Altos.
44. Grosveld F. Activation by locus control regions? Curr. Opin. Genet. 9:1999;152-157.
45. Grosveld F., van Assendelft G.B., Greaves D.R., Kollias G. Position-independent, high-level expression of human β-globin gene in transgenic mice. Cell. 51:1987;975-985.
46. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of DNA polymerase β gene segment in T-cells using cell type-specific gene targeting. Science. 263:1994;103-106.
47. Guillemin R., Brazeau P., Bohlen P., Esch F., Ling N., Wehrenberg W.B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 218:1982;585-587.
48. Hammer R.E., Brinster R.L., Rosefeld M.G., Evans R.M., Mayo K.E. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature. 315:1985;413-415.
49. Harbers K., Jähner D., Jaenisch R. Microinjection of cloned retroviral genomes into mouse zygotes: integration and expression in the animal. Nature. 293:1981;540-542.
50. Harvey S. Growth hormone release. Harvey S., Scanes C.G., Daughaday W.H. Growth Hormone. 1995;97-130 CRC Press, Boca Raton.
51. Heinrichs S.C., Stenzel-Poore M.P., Gold L.H., Battenberg E., Bloom F.E., Koob G.F., Vale W.W., Merlo Pich E. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74:1996;303-311.
52. Herman J.P., Wiegand S.J., Watson S.J. Regulation of basal corticotrophin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology. 127:1990;2408-2417.
53. Higgs D.R., Wood W.G., Jarman A.P., Sharpe J., Lida J., Pretorius I.-M., Ayyub H. A major positive regulatory region located far upstream of the human α-globin gene locus. Genes Dev. 4:1990;1588-1601.
54. Hochgeschwender U., Brennan M.B. Mouse knockouts rule OK. Nature. 375:1995;543.
55. Huber M.C., Bosch F.X., Sippel A.E., Bonifer C. Chromosomal position effect in chicken lysozyme gene transgenic mice are correlated with suppression of DNase I hypersensitive site formation. Nucleic Acid Res. 22:1994;4195-4201.
56. Iannaccone P.M., Taborn G.U., Garton R.L., Caplice M.D., Brenin D.R. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 163:1994;288-292.
57. Jones B.K., Monks B.R., Liebhaber S.A., Cooke N.E. The human growth hormone gene is regulated by multicomponent locus control region. Mol. Cell. Biol. 15:1995;7010-7021.
58. Karolyi I.J., Burrows H.L., Ramesh T.M., Nakajima M., Lesh J.S., Seong E., Camper S.A., Seasholtz A.F. Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice. Proc. Natl. Acad. Sci. USA. 96:1999;11595-11600.
59. Kaye W.H., Gwirtsman H.E., George D.T., Ebert M.H., Jimerson D.C., Tomai T.P., Chrousos G.P., Gold P.W. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function and intensity of depression. J. Clin. Endocrinol. Metab. 64:1987;203-208.
60. Keegan C.E., Karolyi I.J., Knapp L.T., Bourbonais F.J., Camper S.A., Seasholtz A.F. Expression of corticotropin-releasing hormone transgenes in neurons of adult and developing mice. Mol. Cell. Neurosci. 5:1994;505-514.
61. Kioussis D., Festenstein R. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Biol. 7:1997;614-619.
62. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., Hata T., Watanabe Y., Fujita K., Nagatsu T. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J. Biol. Chem. 270:1995;27235-27243.
63. Kobayashi K., Salo H. Dopamine deficiency in mice. Brain Dev. 22(Suppl. 1):2000;S54-S60.
64. Kornberg R.D. RNA polymerase II: transcription control. Trends Biochem. Sci. 21:1996;325-326.
65. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 44:1985;283-292.
66. Lacy E., Roberts S., Evans E.P., Burtenshaw M.D., Costantini F.D. A foreign β-globin gene in transgenic mice: integration at abnormal chromosomal positions and expression in inappropriate tissues. Cell. 34:1983;343-358.
67. M.A. Lawson, L.A. Macconell, J. Kim, B.T. Powl, S.B. Nelson, P.L. Mellon, Neuron-specific expression in vivo by defined transcription regulatory elements of the GnRH gene, Endocrinology 143 (2002) 1404-1412.
68. Li X.-Y., Virbasius A., Zhu X., Green M.R. Enhancement of TBP binding by activators and general transcription factors. Nature. 399:1999;605-609.
69. Lovejoy D.A., Aubry J.M., Turnbull A., Sutton S., Potter E., Yehling J., Rivier C., Vale W.W. Ectopic expression of the CRF-binding protein: minor impact on HPA axis regulation but induction of sexually dimorphic weight gain. J. Neuroendocrinol. 10:1998;483-491.
70. Low M.J., Otero-Corchon V., Parlow A.F., Ramirez J.L., Kumar U., Patel Y.C., Rubinstein M. Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J. Clin. Invest. 107:2001;1571-1580.
71. Lui J., Merlie J.P., Todd R.D., O'Malley K.L. Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using founder analysis. Brain Res. Mol. Brain Res. 50:1997;33-42.
72. Majzoub J.A., Muglia L.J., Martinez C., Jacobson L. Molecular and transgenic studies of the corticotropin-releasing hormone gene. Ann. NY Acad. Sci. 771:1996;293-300.
73. Mansour S.L. Gene targeting in murine embryonic stem cells: introduction of specific alterations into the mammalian genome. Genet. Anal. Tech. Appl. 7:1990;219-227.
74. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78:1981;7634-7638.
75. Mason A.J., Hayflick J.S., Zoeller R.T., Young III W.S., Phillips H.S., Nikolics K., Seeburg P.H. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science. 234:1986;1366-1371.
76. Mason A.J., Pitts S.L., Nikolics K., Szonyi E., Wilcox J.N., Seeburg P.H., Stewart T.A. The hypogonadal mouse: reproductive functions restored by gene therapy. Science. 234:1986;1372-1378.
77. Matsumoto K., Kakidani H., Anzai M., Nakagata N., Takahashi A., Takahashi Y., Miyata K. Evaluation of an antisense RNA transgene for inhibiting growth hormone gene expression in transgenic rats. Dev. Genet. 16:1995;273-277.
78. Matsumoto K., Kakidani H., Takahashi A., Nakagata N., Anzai M., Matsuzaki Y., Takahashi Y., Miyata K., Utsumi K., Iritani A. Growth retardation in rats whose growth hormone gene expression was suppressed by antisense RNA transgene. Mol. Reprod. Dev. 36:1993;53-58.
79. Mayo K.E., Hammer R.E., Swanson L.W., Brinster R.L., Rosenfeld M.C., Evans R.M. Transgenic mice expressing a human growth hormone-releasing factor gene. Mol. Endocrinol. 2:1988;606-612.
80. P.J. Miettinen et al, J.E. Berger, J. Meneses, Y. Phung, R.A. Pedersen, Z. Werb, R. Derynck, Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor, Nature 376 (1995) 337-341.
81. Mellon P.L., Windle J.J., Goldsmith P.C., Padula C.A., Roberts J.L., Weiner R.I. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis. Neuron. 5:1990;1-10.
82. Min N., Joh T.H., Corp E.S., Baker H., Cubells J.F., Son J.H. A transgenic mouse model to study transsynaptic regulation of tyrosine hydroxylase gene expression. J. Neurochem. 67:1996;11-18.
83. Moore K.E. Interactions between prolactin and dopaminergic neurones. Biol. Reprod. 36:1987;47-58.
84. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature. 373:1995;427-432.
85. Murphy D., Bishop A., Rindi G., Murphy M.N., Stamp G., Hanson J., Polak J., Hogan B.L.M. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary: a possible model for human multiple endocrine neoplasia. Am. J. Pathol. 129:1987;552-566.
86. Nelson D.H. Cushings syndrome. De Groot L.J. Endocrinology. vol. 2:1989;1660-1675 WB Saunders Company, Philadelphia.
87. Nelson R.J. The use of genetic "knockout" mice in behavioral endocrinology research. Horm. Behav. 31:1997;188-196.
88. Nikolov D.B., Chen H., Halay E.D., Hoffman A., Roeder R.G., Burley S.K. Crystal structure of a human TATA box-binding protein/TATA element complex. Proc. Natl. Acad. Sci. USA. 93:1996;4862-4867.
89. Nogues N., Magnan E., De Grandis P., Butz M., Kineman R.D., Kopchick J.J., Frohman L.A. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice. Mol. Cell. Endocrinol. 137:1998;161-168.
90. Nowak M.A., Boerlijst M.C., Cooke J., Smith J.M. Evolution of genetic redundancy. Nature. 388:1997;167-171.
91. Ornitz D.M., Palmiter R.D., Hammer R.E., Brinster R.L., Swift G.H., MacDonald R.J. Specific expression of an elastase-human growth hormone fusion gene in pancreatic acinar cells of transgenic mice. Nature. 313:1985;600-602.
92. ′ -sequences specifying gonadotrophin-releasing hormone expression in adult mice Mol. Endocrinol. 13:1999;2203-2211.
93. Pardy K. Reporter enzymes for the study of promoter activity. Mol. Biotechnol. 2:1994;23-28.
94. Pepin M.-C., Pothier F., Barden N. Impaired glucocorticoid-receptor function in mice bearing antisense RNA transgenes. Nature. 355:1992;725-728.
95. Piccioli P., Di Luzio A., Amann R., Schuligoi R., Surani M.A., Donnerer J., Cattaneo A. Neuroantibodies: ectopic expression of recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron. 15:1995;373-384.
96. Queen C., Baltimore D. Immunoglobulin gene transcription is activated by downstream elements. Cell. 33:1983;741-748.
97. Radovick S., Ticknor C.M., Nakaayama Y., Notides A.C., Rahman A., Weintraub B.D., Cutler G.B. Jr., Wondisford F.E. Evidence for the direct estrogen regulation of the human gonadotropin-releasing hormone gene. J. Clin. Invest. 88:1991;1649-1655.
98. Rivier C., Vale W. Interaction of corticotrophin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology. 113:1983;939-942.
99. Rivier J., Speiss J., Thorner M., Vale W. Characterization of growth hormone-releasing factor from a pancreatic islet tumor. Nature. 300:1982;276-278.
100. Roeder R.G. The role of general initiation factor in transcription by RNA polymerase II. Trends Biochem. Sci. 21:1996;327-334.
101. Routtenberg A. Knockout mouse fault lines. Nature. 374:1995;314.
102. Rubenstein M., Liu B., Goodman R.H., Low M.J. Targeted expression of somatostatin in vasopressinergic magnocellular hypothalamic neurons of transgenic mice. Mol. Cell. Neurosci. 3:1992;152-161.
103. Sasaoka T., Kobayashi K., Nagatsu I., Takahashi R., Kimura M., Yokoyama M., Nomura T., Katsuki M., Nagatsu T. Analysis of the human tyrosine hydroxylase promoter-chloramphenicol acetyltransferase chimeric gene expression in transgenic mice. Brain Res. Mol. Brain Res. 16:1992;274-286.
104. Sawchenko P.E., Aria C.A., Mortrud M.T. Local tetrodotoxin blocks chronic stress effect on corticotropin-releasing factor and vasopressin messenger ribonucleic acids in hypophysiotropic neurons. J. Neuroendocrinol. 5:1993;341-348.
105. ′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors Brain Res. Mol. Brain Res. 74:1991;1-14.
106. Selden R.F., Skoskiewicz M.J., Howie K.B., Russell P.S., Goodman H.M. Regulation of human insulin gene expression in transgenic mice. Nature. 321:1986;525-528.
107. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238.
108. Skynner M.J., Slater R., Sim J.A., Allen N.D., Herbison A.E. Promoter transgenics reveal multiple gonadotropin-releasing hormone-I-expressing cell populations of different embryological origin in mouse brain. J. Neurosci. 19:1999;5955-5966.
109. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., Chen R., Marchuk Y., Hauser C., Bentley C.A., Sawchenko P.E., Koob G.F., Vale W., Lee K.F. Corticotrophin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron. 20:1998;1093-1102.
110. Son J.H., Min N., Joh T.H. Early ontogeny of catecholaminergis cell lineage in brain and peripheral neurons monitored by tyrosine hydroxylase-lacZ transgene. Brain Res. Mol. Brain Res. 36:1996;300-308.
111. Spergel D.J., Kruth U., Hanley D.F., Sprengel R., Seeburg P.H. GABA- and glutamate-activated channels in green fluorescent protein-tagged gonadotropin-releasing hormone neurons in transgenic mice. J. Neurosci. 19:1999;2037-2050.
112. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., Vale W. Development of cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:1992;3378-3386.
113. Stenzel-Poore M.P., Duncan J.E., Rittenberg M.B., Bakke A.C., Heinrichs S.C. CRH overproduction in transgenic mice: behavioural and immune system modulation. Ann. NY Acad. Sci. 780:1996;36-48.
114. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 5:1994;2579-2584.
115. Stief A., Winter D.M., Strätling W.H., Sippel A.E. A nuclear DNA attachment element mediates elevated and position-independent gene activity. Nature. 341:1989;343-345.
116. Struthers R.S., Vale W.W., Arias C., Sawchenko P.E., Montminy M.R. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature. 350:1991;622-624.
117. Suter K.J., Song W.J., Sampson T.L., Wuarin J.P., Saunders J.T., Dudek F.E., Moenter S.M. Genetic targeting of green fluorescent protein to gonadotropin-releasing hormone neurons: characterization of whole-cell electrophysiological properties and morphology. Endocrinology. 141:2000;412-419.
118. Swanson L.W., Simmons D.M., Arriza J., Hammer R., Brinster R., Rosenfeld M.G., Evans R.M. Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes. Nature. 317:1985;363-366.
119. Tannebaum G.S., Martin J.B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology. 98:1976;562-570.
120. Thomas J.H. Thinking about genetic redundancy. Trends Genet. 9:1993;395-399.
121. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
122. Trocme C., Sarkis C., Hermel J.M., Duchateau R., Harrison S., Simonneau M., Al-Shawi R., Mallet J. CRE and TRE sequences of the rat tyrosine hydoxylase promoter are required for basal expression in adult mice but not in the embryo. Eur. J. Neurosci. 10:1998;508-521.
123. Tronche F., Kellendonk C., Kretz O., Gass P., Anlag K., Orban P.C., Bock R., Klein R., Schutz G. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23:1999;99-103.
124. Vale W., Speiss J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotroph and β-endorphin. Science. 213:1981;1394-1397.
125. Venihaki M., Majzoub J.A. Animal models of CRH deficiency. Front Neuroendocrinol. 20:1999;122-145.
126. Verrijzer C.P., Tijan R. TAFs mediate transcriptional activation and promoter selectivity. Trend Biochem. Sci. 21:1996;338-342.
127. ′ -flanking region of insulin and chymotrypsin Nature. 306:1983;557-561.
128. Waschek J.A. Transgenic targeting of neuroendocrine peptide genes in the hypothalamic-pituitary axis. Mol. Neurobiol. 10:1995;205-216.
129. Weiner R.I., Wetsel W., Goldsmith P., Martinez de la Escalera G., Windle J., Padula C., Choi A., Negro-Vilar A., Mellon P. Gonadotropin-releasing hormone neuronal cell lines. Front Neuroendocrinol. 13:1992;95-119.
130. Wells T., Flavell D.M., Wells S.E., Carmignac D.F. Robinson ICAF. Effects of growth hormone secretagogues in the transgenic growth-retarded (Tgr) rat. Endocrinology. 138:1997;580-587.
131. Wells T., Houston P.A. Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization. J. Neuroendocrinol. 13:2001;496-504.
132. Wolfe A.M., Wray S., Westphal H., Radovick S. Cell-specific expression of the human gonadotropin-releasing hormone gene in transgenic animals. J. Biol. Chem. 271:1996;20018-20023.
133. Yang C., Kim H.S., Seo H., Kim K.S. Identification and characterization of potential cis-regulatory elements governing transcriptional activation of rat tyrosine hydroxylase gene. J. Neurochem. 71:1998;1358-1368.
134. Yates F.E., Russell S.M., Dallman M.F., Hedge G.A., McCann S.M., Dhariwal A.P.S. Potentiation by vasopressin of corticotropin release induced by corticotropin-releasing factor. Endocrinology. 88:1971;3-15.
135. Zeng Q., Carter D.A., Murphy D. Cell specific expression of a vasopressin transgene in rats. J. Neuroendocrinol. 6:1994;469-477.